Motilal Oswal has reiterated a BUY call on Glenmark Pharma, with a target price of Rs2,610 and an implied upside of 19% from the current market price of Rs2,201.

Torrent Pharmaceuticals has emerged from its latest quarter with renewed momentum, and ICICI Securities has kept its stance at BUY with a target of Rs 5,100, implying about 15% upside from the Rs 4

Prabhudas Lilladher has reiterated a BUY call on Sun Pharmaceutical Industries, setting a target price of Rs 2,070 versus a current market price of Rs 1,845. The broker’s latest Q4

BOB Capital Markets has reiterated its BUY recommendation on Lupin with a revised target price of Rs 2,900, implying an upside potential of nearly 22% from the cur

ICICI Securities has upgraded Cipla to a BUY rating with a revised target price of Rs 1,550, implying a potential upside of nearly 19% from the current market price of Rs 1,306.

Motilal Oswal Financial Services has reiterated a BUY call on Laurus Labs, assigning a target price of Rs 1,280, implying an upside of nearly 19% from the current market price of Rs 1,076.